PSCI 2024 ANNUAL REPORT: THE PHARMACEUTICAL SUPPLY CHAIN INITIATIVE (PSCI) MARKING A YEAR OF GLOBAL IMPACT
3 June 2025 –The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2024 Annual Report, celebrating a year of strategic transformation and measurable progress in building responsible supply chains across the pharmaceutical and healthcare sectors.
AUDIT:
- 1,208 audits now available on the PSCI platform
- 9,500+ downloads by members
- Launch of updated Self-Assessment Questionnaire (SAQ) templates
- Development of the new Link digital platform progressed in 2024, with launch planned for 2025.
CAPABILITY BUILDING:
- 1,100+ webinar attendees across 22 webinars.
- 1,150+ participants at three Supplier Conferences in China and India
- 37 Learnster courses now available, including new content on renewable energy and biodiversity
- 2,900+ users and 2,100+ supplier sites registered on the PSCI Link platform
PROJECTS:
- 11 member-led projects endorsed, with $300k+ invested
- Continued collaboration with the Energize program, supporting a landmark multi-buyer renewable energy agreement
SUPPLIER PARTNERSHIP:
- 12 Supplier Partners joined in 2024
- First Supplier Partner Forum held, fostering dialogue on audit value, Scope 3 emissions, and regional support
LEADERSHIP REFLECTIONS
Deirdre O’Reilly, 2024 PSCI Chair, reflected: “When our founding members joined together in 2013, they had a vision of crystallizing their collective knowledge to create a transparent, efficient, and sustainable supply chain. Reflecting on the past decade, it’s clear that we’ve made tremendous advances towards that original vision, and understand what remains to be achieved on the road ahead.”
Rob Williams, 2025 PSCI Chair, added:“With over 2,000 suppliers reached and a growing global presence, PSCI is uniquely positioned to shape the future of responsible supply chains. In 2025, we look forward to launching our upgraded digital platform, expanding our presence in China, and deepening our partnerships to scale impact